WO1992015692A1 - Novel plasmid - Google Patents
Novel plasmid Download PDFInfo
- Publication number
- WO1992015692A1 WO1992015692A1 PCT/JP1992/000267 JP9200267W WO9215692A1 WO 1992015692 A1 WO1992015692 A1 WO 1992015692A1 JP 9200267 W JP9200267 W JP 9200267W WO 9215692 A1 WO9215692 A1 WO 9215692A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasmid
- region
- gene
- dna
- dna fragment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Definitions
- the present invention relates to a novel plasmid, and more particularly, it is capable of replicating in Escherichia coli and cyanobacterial cells containing a DNA fragment containing the OriA region of a plasmid pBAl derived from the cyanobacterium Anacystis nidulans.
- Shuttle vector plasmid a novel plasmid, and more particularly, it is capable of replicating in Escherichia coli and cyanobacterial cells containing a DNA fragment containing the OriA region of a plasmid pBAl derived from the cyanobacterium Anacystis nidulans.
- the cyanobacterium Anacystis nidulans resembles the photosynthesis mechanism of higher plants, especially red algae, and uses the light from the sun as an energy source to biosynthesize organic substances from water, carbon dioxide and a few inorganic salts, It can grow vegetatively.
- A. nidulans is unicellular and makes colonies on an agar medium.
- the R2 strain is easy to take up DNA into cells and can be transformed by microbial genetic methods.
- heterologous proteins using the R2 strain include the ability of human ribonuclease, Bonnic hydrhydrase and Escherichia coli 1 ac IQ repressor protein [GD Price and ⁇ . ⁇ . Badger, Plant Physiol. 91 : 505-513
- the 6301 strain Because of the size of the gene that can be inserted into the vector, There are many points that are difficult to handle due to genetic manipulation, such as the fact that there are few restriction enzyme recognition sites that can be used for cloning. Also, the 6301 strain has a drawback that it is harder to incorporate gene DNA into cells than the R 2 strain, and as a result, the transformation efficiency is lower than that of the R 2 strain. As a method for improving the transformation efficiency of the 6301 strain, H. Daniell et al. [Proc. Natl. Acad. Sci.
- a 83: 2546-2550 (1986)] proposes that cells of the 6301 strain be treated with EDTA-Lysozyrae to form permeaplasts to facilitate the uptake of DNA.
- this method has succeeded in increasing the transformation efficiency of the 6301 strain, but the operation is time-consuming and complicated, and the cells are damaged by EDTA-lysozyme treatment. Do not give
- the present inventors have first made diligent efforts to reduce the size of the plasmid in order to improve the transformation efficiency of the A. nidulans 6301 strain and to construct a plasmid that is easy to handle in gene manipulation.
- pBAl endogenous ⁇ plasmid
- a shuttle vector plasmid capable of replicating in Escherichia coli and cyanobacterial cells comprising:
- the “OriA region of the plasmid pBAl derived from Anacystis nidulahs” (hereinafter sometimes abbreviated as “OriA”), which forms the plasmid of the present invention, is
- the replication initiation region derived from plasmid pBA1 showing [K.
- the size of the gene fragment may be generally in the range of 2.8-8.0 kb, preferably 2.8-4.4 kb.
- an Ori A region-containing DNA fragment of about 4.4 kb obtained by cutting pBAl with restriction enzymes XhoI and BamHI, PvuII and BamHI An Ori A region-containing DNA fragment having a size of about 3.3 kb obtained by excision is exemplified.
- the “multi-cloning region” (hereinafter sometimes abbreviated as “MC region”) is composed of a sequence (polylinker sequence) having various restriction enzyme recognition sites.
- C ⁇ 1E1 plasmid pUC used as an E. coli cloning vector for example, EcoRI, Sacl, Kpnl, Smal derived from pUC18 , Xma l, B amH I, X bal, S al I, Ac cl, H incl I, Ps tl, Sph l, DNA fragments of 55bp with restriction enzyme recognition sites of H K ind III is Ru are included.
- MC regions derived from pUC12, pUC13, pUC19 and the like can be used, and MC regions derived from the phage vector M13 of Escherichia coli can also be used.
- chemically synthesized MC regions can be used.
- a region in which the gene defined by the rop region, including the OriE region derived from Co 1 El-type plasmid, which can be used in combination with 0 ri A and the MC region has been removed.
- Ori EJ means the replication initiation region of Co 1 E1 type plasmid used in Escherichia coli and having a copy number of 20 to 30 per cell body.
- a typical example of such OriE is a size that can be cut out from plasmid PBR322 using restriction enzymes PvulI, Aval, BamHI, Eco47III, EcoRV, PstI, etc.
- a DNA fragment containing 0 riE containing 1.5 to 4. lkb, preferably 1.5 to 2.5 kb, and a DNA fragment containing 0 riE derived from plasmid pUC18 or the like are also used. can do.
- OriE-containing DNA fragments can contain an ampicillin resistance gene (a drug resistance gene such as Amp, etc.) which can be a marker for cloning.
- ampicillin resistance gene a drug resistance gene such as Amp, etc.
- the plasmid provided by the present invention is the same as that described above for 0 ri A, MC As long as it has a DNA fragment containing the region and the three essential gene regions of OriE, DNA fragments carrying other genetic information, such as a DNA fragment containing the ampicillin resistance gene that is an antibiotic resistance marker, chloram Although it may further include a DNA fragment containing a phenicol resistance gene, a typical example is substantially composed of a DNA fragment containing each of the three gene regions Ori A, MC region and Ori E, and has a molecular weight of The plasmids are about 4.48 megadalton (about 6.9 kb), about 4.15 megadalton (about 6.4 kb), and about 3.76 megadalton (about 5.8 kb), respectively. These are two types of plasmids, which the inventors have named "plasmid pBAXi 8" and "plasmid p BAX20J", respectively.
- the molecular weight of plasmid is a value measured by agarose gel electrophoresis.
- FIG. 1 is a restriction map of plasmid p BAX18
- FIG. 2 is a restriction map of plasmid p BAX20
- FIG. 3 is a construction diagram of plasmids AX18 and p BAX20.
- FIGS. 1 and 2 show restriction maps of plasmids pBAX18 and PBAX20. Plasmid pBAX18 Plasmid ⁇ 20 Restriction enzyme Recognition site Recognition site of degradation fragment
- the plasmids pBAX18 and pBAX20 of the present invention having the characteristics as described above can be produced, for example, as follows. First, the preparation of a 0 riA-containing DNA fragment of the plasmid pBal1 derived from Anakistis nidurans is performed, for example, by the shuttle vector PBAS 18 [K. Shinozaki et al., Gene 19 : 221-224 (1982)] in E. coli (T.
- a DNA fragment containing 0 riA of b and about 3.3 kb is obtained. 5 'protruding ends of these DNA fragments can be flat smooth terminated by T 4 DNA polymerase optionally.
- the MC region of plasmid pUC can be obtained, for example, by cutting out plasmid pUC18 using restriction enzymes EcoRI and HindIII.
- the source of DNA fragments containing the OriE region of Co I El plasmid and the region where the gene defined by the rop region has been removed is Co 1 E1 plasmid. It is convenient to use the representative plasmid PBR322.
- DNA fragment of about 2. 5 kb containing Or i E and MC region is, the combined and 0 ri A containing DNA fragment prepared as described above, by the action of T 4 D NA ligase, and purpose
- the resulting plasmids pBAX 18 and pBAX 20 can be obtained.
- the construction diagrams of plasmids pBAXl8 and PBAX20 are shown in Fig. 3, and their more specific preparation methods will be described in more detail in Examples below.
- the plasmid of the present invention thus prepared is a shuttle vector having an OriE region capable of autonomous replication in Escherichia coli cells and an OriA region capable of autonomous replication in Anakisitis nidulans cells. It is. Therefore, the plasmid of the present invention can be prepared in large quantities using fast-growing Escherichia coli, and the plasmid DNA prepared in such a large quantity can be used to prepare a run such as Anakistis nidulans. Algae cells can be efficiently transformed.
- the plasmid of the present invention since it has a multi-cloning region, it can be used as a recognition site for inserting a (foreign) gene, in addition to an EcoRI recognition site that is used only in the plasmid pBAS18. Recognition sites such as I, BamHI, Xbal, Scal, and EcoRV can be used.
- the size of the plasmid of the present invention is about half (6.9 kb to 5.9 kb) of the plasmid pBAS18 (12 kb) due to the removal of the DNA portion other than the OriA region of the plasmid pBAl. This allows the plasmid of the present invention to introduce a (foreign) gene larger than the (foreign) gene which can be introduced into plasmid pBAS18.
- the introduction of the plasmid of the present invention having the above-mentioned properties in genetic engineering into a host cell can be performed by a method known per se, for example, DA Lightfoot et.al., J. General Microbiol. 134: 1509-1514 ( 1988) etc. Can be done in a way.
- the transformation efficiency of the Anakistis nidulans 6301 strain thus transformed can be about 1000 times higher than the value obtained by transformation using plasmid pBAS18. Therefore, by using the plasmid of the present invention, even when a (foreign) gene is introduced, it is possible to easily select cells having the plasmid into which the target gene has been inserted.
- Structural genes that can be incorporated into the plasmid of the present invention include structural genes derived from Anakistis nidueurans, structural genes derived from other cyanobacterial cells, structural genes derived from other bacteria, and structural genes derived from higher animal and plant cells. The origin is not limited at all.
- the structural gene that can be incorporated into the plasmid of the present invention may be a chemically synthesized structural gene. Such an example as a chemical synthetic human over Super O dimethylsulfoxide 'dismutase [h ⁇ SOD, h-SO DA 1 a 6 ( see Japanese Patent Laid-Open No. 2 156 884), etc.] genes Ru mentioned.
- I 9 Ounits (7.5 ⁇ was added and incubated for 3 hours at 37.
- the DNA was recovered by ethanol precipitation and electrophoresed on a 1.5% agarose gel.
- the DNA was electroeluted from the gel, phenol-chloroform treated, and ethanol precipitated for purification.
- pBR322 (EcoRI-Hindii II, AP treatment) DNAO.2 £ g and multicloning site DNA0.2 jfig (1 TE (1 OBMT ris—HC 1 (pH 8.0), 1 mM EDTA) .1 jttl and Takara Ligation Kit A solution 241-1 were added to the mixture, and the mixture was stirred well. Add Takara ligation Kit B solution 3 1 to this solution and incubate at 16 for 4 hours.
- the DNA was incorporated into the cells by incubating for 2 minutes. To this suspension was added 1.8 ml of 2 ⁇ (16 gZl tryptone, 10 g / 1 yeast extract, 5 g ZlNaCl) liquid medium, and after shaking culture at 37 ⁇ for 1 hour, LB (lOgZl tryptone, 8 g71 NaCl) , 5 gZl yeast extract extract) The plate was plated on an agar medium (containing 5 ml of ampicillin). Plasmids were prepared from the obtained colonies, and colonies containing the desired plasmid (pBR322M) were screened by analyzing a restriction enzyme map. The screened colonies were cultured in 200011 2 ⁇ liquid medium (containing 100 igZml ampicillin) and plasmid DN
- A was prepared in large quantities by the SDS-Arikari method.
- a colony holding the desired plasmid (pBAX20) is screened, and cultured in 200 ml of 2YT liquid medium (containing 100 zgZml ampicillin), and the plasmid DNA is purified.
- SDS prepared by the alkaline method.
- Transformation efficiency of colonies obtained in this way when using the present invention plasmids 10- 3 ⁇ 10 - 4 cellsZ g Burasumi de DN A indicates a value of, in the case of using a plasmid PBAS 18 (10 It succeeded in obtaining an efficiency approximately 1000 times that of —7 cells (g plasmid DNA).
- the plasmid of the present invention can be prepared in large amounts using Escherichia coli, can be replicated in Escherichia coli and cyanobacterial cells, and is useful as a shuttle vector for expression of various structural genes in cyanobacterial cells. is there.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92905782T DK0576674T3 (da) | 1991-03-08 | 1992-03-06 | Hidtil ukendt plasmid |
EP92905782A EP0576674B1 (en) | 1991-03-08 | 1992-03-06 | Novel plasmid |
KR1019920702777A KR100213526B1 (ko) | 1991-03-08 | 1992-03-06 | 신규 플라스미드 |
DE69229392T DE69229392T2 (de) | 1991-03-08 | 1992-03-06 | Neuartiges plasmid |
FI925004A FI107736B (fi) | 1991-03-08 | 1992-11-05 | Escherichia colissa ja syanobakteereissa replikoituvia sukkulavektoriplasmideja ja niitä sisältäviä syanobakteerisoluja |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3/67774 | 1991-03-08 | ||
JP3067774A JP2574549B2 (ja) | 1991-03-08 | 1991-03-08 | 新規プラスミド |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992015692A1 true WO1992015692A1 (en) | 1992-09-17 |
Family
ID=13354631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1992/000267 WO1992015692A1 (en) | 1991-03-08 | 1992-03-06 | Novel plasmid |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0576674B1 (ja) |
JP (1) | JP2574549B2 (ja) |
KR (1) | KR100213526B1 (ja) |
AT (1) | ATE181109T1 (ja) |
AU (1) | AU638892B2 (ja) |
CA (1) | CA2082407A1 (ja) |
DE (1) | DE69229392T2 (ja) |
DK (1) | DK0576674T3 (ja) |
ES (1) | ES2134209T3 (ja) |
FI (1) | FI107736B (ja) |
HU (1) | HU216075B (ja) |
IL (1) | IL101142A (ja) |
RU (1) | RU2122027C1 (ja) |
TW (1) | TW213951B (ja) |
WO (1) | WO1992015692A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06253820A (ja) * | 1993-02-26 | 1994-09-13 | Hideo Fukuda | 細菌のエチレン生成酵素をコードする遺伝子を含むdna断片を含有するベクターで形質転換させたらん藻の形質転換体と、その形質転換体を利用したエチレン製造方法 |
JPH10150984A (ja) * | 1996-11-19 | 1998-06-09 | Hagiwara Yoshihide | 抗体分子の製造方法 |
RU2485384C2 (ru) * | 2011-09-01 | 2013-06-20 | Вадим Андреевич Иванов | Фронтально-козловой трубоукладчик |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62175192A (ja) * | 1985-10-21 | 1987-07-31 | Fujisawa Pharmaceut Co Ltd | ヒトインスリン様成長因子1の製造法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63294788A (ja) * | 1987-05-27 | 1988-12-01 | Nikka Uisukii Kk | ベクタ−、遺伝子の検出方法及び蛋白質の発現方法 |
JPH0284187A (ja) * | 1988-09-20 | 1990-03-26 | Agency Of Ind Science & Technol | シャトルベクターYEUp3及び菌体内にYEUp3を保持する微生物菌株 |
JPH0767393B2 (ja) * | 1991-03-13 | 1995-07-26 | 萩原 義秀 | ポリペプチドの発現方法 |
-
1991
- 1991-03-08 JP JP3067774A patent/JP2574549B2/ja not_active Expired - Fee Related
-
1992
- 1992-03-04 IL IL101142A patent/IL101142A/en not_active IP Right Cessation
- 1992-03-06 CA CA002082407A patent/CA2082407A1/en not_active Abandoned
- 1992-03-06 DK DK92905782T patent/DK0576674T3/da active
- 1992-03-06 AT AT92905782T patent/ATE181109T1/de not_active IP Right Cessation
- 1992-03-06 WO PCT/JP1992/000267 patent/WO1992015692A1/ja active IP Right Grant
- 1992-03-06 HU HUP9203485A patent/HU216075B/hu not_active IP Right Cessation
- 1992-03-06 RU RU92016430A patent/RU2122027C1/ru not_active IP Right Cessation
- 1992-03-06 ES ES92905782T patent/ES2134209T3/es not_active Expired - Lifetime
- 1992-03-06 AU AU13611/92A patent/AU638892B2/en not_active Ceased
- 1992-03-06 EP EP92905782A patent/EP0576674B1/en not_active Expired - Lifetime
- 1992-03-06 TW TW081101714A patent/TW213951B/zh active
- 1992-03-06 DE DE69229392T patent/DE69229392T2/de not_active Expired - Fee Related
- 1992-03-06 KR KR1019920702777A patent/KR100213526B1/ko not_active Expired - Fee Related
- 1992-11-05 FI FI925004A patent/FI107736B/fi not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62175192A (ja) * | 1985-10-21 | 1987-07-31 | Fujisawa Pharmaceut Co Ltd | ヒトインスリン様成長因子1の製造法 |
Non-Patent Citations (1)
Title |
---|
Gene, Vol. 19, 1982, K. SHINOZAKI et al., "Cloning and characterization of a plasmid DNA from Anacystis-nidulans 6301", p. 221-224. * |
Also Published As
Publication number | Publication date |
---|---|
EP0576674A1 (en) | 1994-01-05 |
AU1361192A (en) | 1992-10-06 |
CA2082407A1 (en) | 1992-09-09 |
FI925004A0 (fi) | 1992-11-05 |
HU216075B (hu) | 1999-04-28 |
IL101142A (en) | 1998-06-15 |
KR100213526B1 (ko) | 1999-08-02 |
AU638892B2 (en) | 1993-07-08 |
ES2134209T3 (es) | 1999-10-01 |
FI107736B (fi) | 2001-09-28 |
DE69229392T2 (de) | 1999-10-07 |
JPH04281793A (ja) | 1992-10-07 |
EP0576674A4 (ja) | 1994-04-27 |
HUT65745A (en) | 1994-07-28 |
JP2574549B2 (ja) | 1997-01-22 |
FI925004L (fi) | 1992-11-05 |
HU9203485D0 (en) | 1993-01-28 |
DE69229392D1 (de) | 1999-07-15 |
ATE181109T1 (de) | 1999-06-15 |
EP0576674B1 (en) | 1999-06-09 |
RU2122027C1 (ru) | 1998-11-20 |
IL101142A0 (en) | 1992-11-15 |
DK0576674T3 (da) | 1999-11-15 |
TW213951B (ja) | 1993-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guttman et al. | Functional analysis of the type III effectors AvrRpt2 and AvrRpm1 of Pseudomonas syringae with the use of a single-copy genomic integration system | |
Rahme et al. | Genetic and transcriptional organization of the hrp cluster of Pseudomonas syringae pv. phaseolicola | |
Nakano et al. | Isolation and characterization of sfp: a gene that functions in the production of the lipopeptide biosurfactant, surfactin, in Bacillus subtilis | |
Zhao et al. | The avrRxo1 gene from the rice pathogen Xanthomonas oryzae pv. oryzicola confers a nonhost defense reaction on maize with resistance gene Rxo1 | |
Lim et al. | Characterization of chromosomal homologs of the plasmid-borne copper resistance operon of Pseudomonas syringae | |
CA2619989C (en) | Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria | |
Tandeau de Marsac et al. | Expression of the larvicidal gene of Bacillus sphaericus 1593M in the cyanobacterium Anacystis nidulans R2 | |
US4713337A (en) | Method for deletion of a gene from a bacteria | |
JP3878207B2 (ja) | osmB プロモータで制御される発現プラスミド | |
CN114410651B (zh) | 玉米灰斑病抗性相关蛋白及其编码基因与应用 | |
Sherman et al. | Construction of a hybrid plasmid capable of replication in the bacterium Escherichia coli and the cyanobacterium Anacystis nidulans | |
Julliot et al. | Use of RP4-prime plasmids constructed in vitro to promote a polarized transfer of the chromosome in Escherichia coli and Rhizobium meliloti | |
WO2012122765A1 (zh) | 一种表面展示家蚕乙醇脱氢酶重组芽孢及其制备方法 | |
WO1992015692A1 (en) | Novel plasmid | |
EP0182562B1 (en) | Process for a thermo-inducible gene expression in gram positive bacteria, bacillus subtilis strains containing plasmids which induce such an expression and portable vector systems | |
JP2002078491A (ja) | 青枯病菌由来の挿入配列因子 | |
US5606022A (en) | Cloning and identification of a two component signal transducing regulatory system from Bacteroides fragilis | |
ZA200503757B (en) | New expression system from Rhodococcus | |
CN115160422A (zh) | 甘薯耐盐抗旱相关蛋白IbMYB44及其编码基因与应用 | |
Yun et al. | Nitrogenase promoter-lacZ fusion studies of essential nitrogen fixation genes in Bradyrhizobium japonicum I110 | |
JP2009514506A (ja) | E.コリ株dsm6601のプラスミド不含のクローン | |
JP3946300B2 (ja) | ビフィズス菌用シャトルベクター及びビフィズス菌プラスミドの複製タンパク質遺伝子 | |
CN103993030A (zh) | 一种大肠杆菌细胞内蛋白酶剪切融合蛋白的方法 | |
RU2114909C1 (ru) | Фрагмент днк, соответствующий области начала репликации, выделенный из плазмиды микроорганизма bacillus thurinqiensis hd73, вектор экспрессии кристаллического белкового токсина b. thurinqiensis, способ получения экзогенного кристаллического белкового токсина b. thurinqiensis в клетках b. thurinqiensis и инсектицидное средство, содержащее бактерии b. thurinqiensis | |
KR100497204B1 (ko) | 유산균으로부터 분리된 신규한 분비신호 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI HU KR RU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 925004 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2082407 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992905782 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992905782 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992905782 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 925004 Country of ref document: FI |